980 related articles for article (PubMed ID: 27490410)
21. Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND Trial.
Ruedy KJ; Parkin CG; Riddlesworth TD; Graham C;
J Diabetes Sci Technol; 2017 Nov; 11(6):1138-1146. PubMed ID: 28449590
[TBL] [Abstract][Full Text] [Related]
22. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
[TBL] [Abstract][Full Text] [Related]
23. The Effects of Subcutaneous Insulin Infusion Versus Multiple Insulin Injections on Glucose Variability in Young Adults with Type 1 Diabetes: The 2-Year Follow-Up of the Observational METRO Study.
Maiorino MI; Bellastella G; Casciano O; Cirillo P; Simeon V; Chiodini P; Petrizzo M; Gicchino M; Romano O; Caruso P; Giugliano D; Esposito K
Diabetes Technol Ther; 2018 Feb; 20(2):117-126. PubMed ID: 29303370
[TBL] [Abstract][Full Text] [Related]
24. Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.
Bolli GB; Kerr D; Thomas R; Torlone E; Sola-Gazagnes A; Vitacolonna E; Selam JL; Home PD
Diabetes Care; 2009 Jul; 32(7):1170-6. PubMed ID: 19389820
[TBL] [Abstract][Full Text] [Related]
25. Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years.
Jakisch BI; Wagner VM; Heidtmann B; Lepler R; Holterhus PM; Kapellen TM; Vogel C; Rosenbauer J; Holl RW;
Diabet Med; 2008 Jan; 25(1):80-5. PubMed ID: 18199134
[TBL] [Abstract][Full Text] [Related]
26. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.
Boland EA; Grey M; Oesterle A; Fredrickson L; Tamborlane WV
Diabetes Care; 1999 Nov; 22(11):1779-84. PubMed ID: 10546007
[TBL] [Abstract][Full Text] [Related]
27. The Association Between HbA
Seyed Ahmadi S; Westman K; Pivodic A; Ólafsdóttir AF; Dahlqvist S; Hirsch IB; Hellman J; Ekelund M; Heise T; Polonsky W; Wijkman M; Schwarcz E; Lind M
Diabetes Care; 2020 Sep; 43(9):2017-2024. PubMed ID: 32641374
[TBL] [Abstract][Full Text] [Related]
28. Hypoglycemia and blood glucose fluctuations in the application of a sensor-augmented insulin pump.
Luo P; Cheng Q; Chen B; Li Y; Wu J; Zhang X; Jiao X; Zhao J; Lv X
Diabetes Technol Ther; 2013 Dec; 15(12):984-9. PubMed ID: 24004044
[TBL] [Abstract][Full Text] [Related]
29. Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes.
Cohen ND; Hong ES; Van Drie C; Balkau B; Shaw J
Diabetes Technol Ther; 2013 Jul; 15(7):544-9. PubMed ID: 23617252
[TBL] [Abstract][Full Text] [Related]
30. Satisfaction with the Use of Different Technologies for Insulin Delivery and Glucose Monitoring Among Adults with Long-Standing Type 1 Diabetes and Problematic Hypoglycemia: 2-Year Follow-Up in the HypoCOMPaSS Randomized Clinical Trial.
Speight J; Holmes-Truscott E; Little SA; Leelarathna L; Walkinshaw E; Tan HK; Bowes A; Kerr D; Flanagan D; Heller SR; Evans ML; Shaw JAM
Diabetes Technol Ther; 2019 Nov; 21(11):619-626. PubMed ID: 31335201
[No Abstract] [Full Text] [Related]
31. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.
Alemzadeh R; Palma-Sisto P; Holzum M; Parton E; Kicher J
Diabetes Technol Ther; 2007 Aug; 9(4):339-47. PubMed ID: 17705689
[TBL] [Abstract][Full Text] [Related]
32. The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study.
Conget I; Castaneda J; Petrovski G; Guerci B; Racault AS; Reznik Y; Cohen O; Runzis S; de Portu S; Aronson R;
Diabetes Technol Ther; 2016 Jan; 18(1):22-8. PubMed ID: 26241790
[TBL] [Abstract][Full Text] [Related]
33. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
[TBL] [Abstract][Full Text] [Related]
34. Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections.
Fatourechi MM; Kudva YC; Murad MH; Elamin MB; Tabini CC; Montori VM
J Clin Endocrinol Metab; 2009 Mar; 94(3):729-40. PubMed ID: 19088167
[TBL] [Abstract][Full Text] [Related]
35. Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes.
Willi SM; Planton J; Egede L; Schwarz S
J Pediatr; 2003 Dec; 143(6):796-801. PubMed ID: 14657831
[TBL] [Abstract][Full Text] [Related]
36. OpT2mise: a randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes-research design and methods.
Aronson R; Cohen O; Conget I; Runzis S; Castaneda J; de Portu S; Lee S; Reznik Y;
Diabetes Technol Ther; 2014 Jul; 16(7):414-20. PubMed ID: 24735134
[TBL] [Abstract][Full Text] [Related]
37. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes.
Bode BW; Steed RD; Davidson PC
Diabetes Care; 1996 Apr; 19(4):324-7. PubMed ID: 8729154
[TBL] [Abstract][Full Text] [Related]
38. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes.
Herman WH; Ilag LL; Johnson SL; Martin CL; Sinding J; Al Harthi A; Plunkett CD; LaPorte FB; Burke R; Brown MB; Halter JB; Raskin P
Diabetes Care; 2005 Jul; 28(7):1568-73. PubMed ID: 15983302
[TBL] [Abstract][Full Text] [Related]
39. Switch to multiple daily injections with insulin glargine and insulin lispro from continuous subcutaneous insulin infusion with insulin lispro: a randomized, open-label study using a continuous glucose monitoring system.
Bode BW; Steed RD; Schleusener DS; Strange P
Endocr Pract; 2005; 11(3):157-64. PubMed ID: 16239201
[TBL] [Abstract][Full Text] [Related]
40. Comparison between sensor-augmented insulin therapy with continuous subcutaneous insulin infusion or multiple daily injections in everyday life: 3-day analysis of glucose patterns and sensor accuracy in children.
Zucchini S; Scipione M; Balsamo C; Maltoni G; Rollo A; Molinari E; Mangoni L; Cicognani A
Diabetes Technol Ther; 2011 Dec; 13(12):1187-93. PubMed ID: 21854193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
